CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-16 | Shah Vinay Chief Financial Officer | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2024-03-25 | Gilliland Robertson H. Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2024-03-25 | Newman James W. Jr. Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2024-03-25 | Truluck Joseph Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-03-25 | Claiborne Cary J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-03-25 | Anderson J. Kermit Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2024-03-25 | Schuyler Kevin Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2024-03-25 | Goodman Tony Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2023-09-29 | Schuyler Kevin Director | Purchase | +700 | $2.74 | $2K | 700 |
| 2023-05-23 | Johnson Bankole A. Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2023-05-23 | Truluck Joseph Chief Financial Officer | Grant or award | +157,500 | 265,139 | ||
| 2023-05-23 | Truluck Joseph Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-05-23 | Stilley William B. III Director | Grant or award | +240,800 | 1,261,779 | ||
| 2023-05-23 | Stilley William B. III Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Schuyler Kevin Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Newman James W. Jr. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Goodman Tony Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Gilliland Robertson H. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Claiborne Cary J Chief Executive Officer | Grant or award | +420,000 | 1,520,000 | ||
| 2023-05-23 | Claiborne Cary J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 |
Page 3 of 10 · 190 trades